Literature DB >> 20690979

Curcumin modulates leukocyte and platelet adhesion in murine sepsis.

Vidula Vachharajani1, Si-Wei Wang, Nilamadhab Mishra, Mohamed El Gazzar, Barbara Yoza, Charles McCall.   

Abstract

OBJECTIVE: Circulating cell-endothelial cell interaction in sepsis is a rate-determining factor in organ dysfunction, and interventions targeting this process have a potential therapeutic value. In this project, we examined whether curcumin, an active ingredient of turmeric and an anti-inflammatory agent, could disrupt interactions between circulating blood cells and endothelium and improve survival in a murine model of sepsis.
METHODS: Mice were subjected to cecal ligation and puncture (CLP) to induce sepsis vs. sham surgery. We studied leukocyte and platelet adhesion in cerebral microcirculation using intravital fluorescent video microscopy technique, blood-brain barrier (BBB) dysfunction using Evans Blue (EB) leakage method, P-selectin expression using dual radiolabeling technique, and survival in mice subjected to Sham, CLP, and CLP with curcumin pre-treatment (CLP + curcumin).
RESULTS: Curcumin significantly attenuated leukocyte and platelet adhesion in cerebral microcirculation, EB leakage in the brain tissue, and improved survival in mice with CLP. P-selectin expression in mice with CLP + curcumin was significantly attenuated compared with CLP in various microcirculatory beds, including brain. Reduction in platelet adhesion was predominantly via modulation of endothelium by curcumin.
CONCLUSION: Curcumin pre-treatment modulates leukocyte and platelet adhesion and BBB dysfunction in mice with CLP via P-selectin expression and improves survival in mice with CLP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20690979      PMCID: PMC2919812          DOI: 10.1111/j.1549-8719.2010.00039.x

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  39 in total

1.  Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation.

Authors:  A Kumar; S Dhawan; N J Hardegen; B B Aggarwal
Journal:  Biochem Pharmacol       Date:  1998-03-15       Impact factor: 5.858

Review 2.  Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa).

Authors:  Nita Chainani-Wu
Journal:  J Altern Complement Med       Date:  2003-02       Impact factor: 2.579

3.  The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma.

Authors:  Aqeel M Siddiqui; Xiaoxuan Cui; Rongqian Wu; Weifeng Dong; Mian Zhou; Maowen Hu; H Hank Simms; Ping Wang
Journal:  Crit Care Med       Date:  2006-07       Impact factor: 7.598

4.  Glucocorticoids inhibit the cerebral microvascular dysfunction associated with sepsis in obese mice.

Authors:  Vidula Vachharajani; Shantel Vital; Janice Russell; L Keith Scott; D Neil Granger
Journal:  Microcirculation       Date:  2006-09       Impact factor: 2.628

5.  Blood-brain barrier derangement in sepsis: cause of septic encephalopathy?

Authors:  B Jeppsson; H R Freund; Z Gimmon; J H James; M F von Meyenfeldt; J E Fischer
Journal:  Am J Surg       Date:  1981-01       Impact factor: 2.565

6.  Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats.

Authors:  Meenakshisundaram Thiyagarajan; Shyam S Sharma
Journal:  Life Sci       Date:  2004-01-09       Impact factor: 5.037

7.  Regional differences in constitutive and induced ICAM-1 expression in vivo.

Authors:  J Panés; M A Perry; D C Anderson; A Manning; B Leone; G Cepinskas; C L Rosenbloom; M Miyasaka; P R Kvietys; D N Granger
Journal:  Am J Physiol       Date:  1995-12

Review 8.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome.

Authors:  J C Marshall; D J Cook; N V Christou; G R Bernard; C L Sprung; W J Sibbald
Journal:  Crit Care Med       Date:  1995-10       Impact factor: 7.598

9.  Septic encephalopathy. Evidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy.

Authors:  B A Mizock; H C Sabelli; A Dubin; J I Javaid; A Poulos; E C Rackow
Journal:  Arch Intern Med       Date:  1990-02

10.  Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group.

Authors:  C L Sprung; P N Peduzzi; C H Shatney; R M Schein; M F Wilson; J N Sheagren; L B Hinshaw
Journal:  Crit Care Med       Date:  1990-08       Impact factor: 7.598

View more
  16 in total

1.  Contribution of the platelet activating factor signaling pathway to cerebral microcirculatory dysfunction during experimental sepsis by ExoU producing Pseudomonas aeruginosa.

Authors:  Maria Cristina Plotkowski; Vanessa Estato; Sabrina Alves Santos; Mauricio Costa Alves da Silva; Aline Silva Miranda; Pedro Elias de Miranda; Vanessa Pinho; Eduardo Tibiriça; Verônica Morandi; Mauro Martins Teixeira; Albanita Vianna; Alessandra Mattos Saliba
Journal:  Pathog Dis       Date:  2015-07-17       Impact factor: 3.166

2.  Adiponectin-deficiency exaggerates sepsis-induced microvascular dysfunction in the mouse brain.

Authors:  Vidula Vachharajani; Christie Cunningham; Barbara Yoza; John Carson; Tushar J Vachharajani; Charles McCall
Journal:  Obesity (Silver Spring)       Date:  2011-10-13       Impact factor: 5.002

Review 3.  The inflammatory response in sepsis.

Authors:  Markus Bosmann; Peter A Ward
Journal:  Trends Immunol       Date:  2012-10-02       Impact factor: 16.687

Review 4.  Epigenetic coordination of acute systemic inflammation: potential therapeutic targets.

Authors:  Vidula Vachharajani; Tiefu Liu; Charles E McCall
Journal:  Expert Rev Clin Immunol       Date:  2014-08-04       Impact factor: 4.473

5.  Curcuminoids limit neutrophil-mediated reperfusion injury in experimental stroke by targeting the endothelium.

Authors:  Janet L Funk; Jennifer B Frye; Grace Davis-Gorman; Allison L Spera; Michael J Bernas; Marlys H Witte; Martin E Weinand; Barbaba N Timmermann; Paul F McDonagh; Leslie Ritter
Journal:  Microcirculation       Date:  2013-08       Impact factor: 2.628

6.  Evaluation of Efficacy of Curcumin as an Add-on therapy in Patients of Bronchial Asthma.

Authors:  Afroz Abidi; Surabhi Gupta; Manu Agarwal; H L Bhalla; Mahip Saluja
Journal:  J Clin Diagn Res       Date:  2014-08-20

7.  Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome.

Authors:  Sreedevi Avasarala; Fangfang Zhang; Guangliang Liu; Ruixue Wang; Steven D London; Lucille London
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

8.  Sirtuin 2 Regulates Microvascular Inflammation during Sepsis.

Authors:  Nancy Buechler; Xianfeng Wang; Barbara K Yoza; Charles E McCall; Vidula Vachharajani
Journal:  J Immunol Res       Date:  2017-04-19       Impact factor: 4.818

9.  Ethanol Exposure Attenuates Immune Response in Sepsis via Sirtuin 2 Expression.

Authors:  Anugraha Gandhirajan; Sanjoy Roychowdhury; Christopher Kibler; Seth R Bauer; Laura E Nagy; Vidula Vachharajani
Journal:  Alcohol Clin Exp Res       Date:  2021-01-23       Impact factor: 3.455

10.  Curcumin inhibits activation induced by urban particulate material or titanium dioxide nanoparticles in primary human endothelial cells.

Authors:  Angélica Montiel-Dávalos; Guadalupe Jazmin Silva Sánchez; Elizabeth Huerta-García; Cristhiam Rueda-Romero; Giovanny Soca Chafre; Irma B Mitre-Aguilar; Ernesto Alfaro-Moreno; José Pedraza-Chaverri; Rebeca López-Marure
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.